ARBS Stock Overview
Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Arterra Bioscience S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.93 |
| 52 Week High | €2.52 |
| 52 Week Low | €1.48 |
| Beta | 1.12 |
| 1 Month Change | -8.10% |
| 3 Month Change | 20.63% |
| 1 Year Change | -22.80% |
| 3 Year Change | -47.27% |
| 5 Year Change | n/a |
| Change since IPO | -43.43% |
Recent News & Updates
Arterra Bioscience S.p.A.'s (BIT:ARBS) P/E Is On The Mark
Feb 13
A Look At The Fair Value Of Arterra Bioscience S.p.A. (BIT:ARBS)
Aug 03Shareholder Returns
| ARBS | IT Biotechs | IT Market | |
|---|---|---|---|
| 7D | -3.5% | -0.8% | -0.1% |
| 1Y | -22.8% | -10.4% | 17.3% |
Return vs Industry: ARBS underperformed the Italian Biotechs industry which returned -10.4% over the past year.
Return vs Market: ARBS underperformed the Italian Market which returned 17.3% over the past year.
Price Volatility
| ARBS volatility | |
|---|---|
| ARBS Average Weekly Movement | 5.2% |
| Biotechs Industry Average Movement | 7.6% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in IT Market | 7.6% |
| 10% least volatile stocks in IT Market | 2.7% |
Stable Share Price: ARBS has not had significant price volatility in the past 3 months.
Volatility Over Time: ARBS's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 30 | Maria Colucci | www.arterrabio.it |
Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions. It develops technological platforms, extraction processes, and raw materials for use in the cosmetics, agriculture, and nutraceutics sectors. Arterra Bioscience S.p.A. was founded in 2003 and is based in Napoli, Italy.
Arterra Bioscience S.p.A. Fundamentals Summary
| ARBS fundamental statistics | |
|---|---|
| Market cap | €12.85m |
| Earnings (TTM) | €983.98k |
| Revenue (TTM) | €4.55m |
13.1x
P/E Ratio2.8x
P/S RatioIs ARBS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARBS income statement (TTM) | |
|---|---|
| Revenue | €4.55m |
| Cost of Revenue | €1.69m |
| Gross Profit | €2.86m |
| Other Expenses | €1.87m |
| Earnings | €983.98k |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.15 |
| Gross Margin | 62.86% |
| Net Profit Margin | 21.64% |
| Debt/Equity Ratio | 5.2% |
How did ARBS perform over the long term?
See historical performance and comparisonDividends
5.2%
Current Dividend Yield68%
Payout RatioDoes ARBS pay a reliable dividends?
See ARBS dividend history and benchmarks| Arterra Bioscience dividend dates | |
|---|---|
| Ex Dividend Date | May 06 2024 |
| Dividend Pay Date | May 08 2024 |
| Days until Ex dividend | 18 days |
| Days until Dividend pay date | 20 days |
Does ARBS pay a reliable dividends?
See ARBS dividend history and benchmarks